Authors
Loading...
This review discusses metabolic reprogramming in glioma, highlighting novel therapeutic targets for better treatment outcomes.
Zhou et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: